EMMA Vienna 2017 | Mutations found in myeloma patients
Brian Walker, PhD of the UAMS Myeloma Institute, Little Rock, AR talks about a study with 500 newly diagnosed patients, where myeloma cells were sequenced to identify present mutations. In this video, Dr Walker discusses the two most commonly mutated genes, KRAS and NRAS, as well as TP53.
Recorded at the 2017 European Multiple Myeloma Academy (EMMA) in Vienna, Austria.
This program was sponsored by Celgene through an unrestricted educational grant to Video Journal of Hematological Oncology.
Get great new content delivered to your inboxSign up